Search results
Phase III trial shows lorlatinib highly effective against ALK-positive non–small cell lung cancer
Medical Xpress· 2 hours agoA large team of medical researchers and doctors has found via phase III clinical trial that the ALK inhibitor lorlatinib is highly effective for treating ...
Male birth control gel is safe and effective, new trial findings show
TODAY via Yahoo News· 2 days agoIf...gynecologist Dr. Brian Nguyen, one of the investigators on the gel clinical trials. “By and...
On-demand sebetralstat speeds symptom relief in hereditary angioedema, clinical trial finds
Medical Xpress· 7 hours ago...according to a study published online May 31 in the New England Journal of Medicine to coincide...
Researchers complete first trial of Black patients with early-stage breast cancer
Medical Xpress· 10 hours agoResults were presented today at the 2024 Annual Meeting of the American Society of Clinical Oncology...
Summit Therapeutics sees stock soar 272% after lung cancer clinical trial - Silicon Valley Business ...
The Business Journals· 5 days agoSummit Therapeutics Inc. investors sent the company's stock up 272% Thursday following the release...
Phase III trial shows donidalorsen cuts attack rate in hereditary angioedema
Medical Xpress· 5 hours agoFor patients with hereditary angioedema, donidalorsen reduces the attack rate, according to a study...
Trial suggests chemo before, after surgery could help those battling esophageal cancer
Medical Xpress· 6 hours agoJennifer Tseng, of Boston Medical Center. The findings were presented at the annual meeting of the...
Ivonescimab Manuscript for HARMONi-A Clinical Trial Results Published in JAMA
Morningstar· 3 days ago(NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) announced that the Journal of the American Medical Association (JAMA) published a manuscript titled, “Ivonescimab...Small ...
Claims of Misconduct Mar MDMA Research for PTSD
High Times· 8 hours agoMedical research into using the psychedelic MDMA to treat post-traumatic stress disorder is being called into question following allegations that a clinical trial ...
FDA selects Larimar Therapeutics for new program inspired by Operation Warp Speed - The Business ...
The Business Journals· 7 hours agoNomlabofusp, an experimental therapy for Friedreich’s ataxia being developed by Larimar Therapeutics, was chosen for the FDA's Support for Clinical Trials Advancing Rare Disease ...